LigoLab, developers of enterprise software for medical laboratories and first care facilities, today announced that its direct-to-consumer platform, TestDirectly, is now equipped with Laboratory Information System (LIS) functionality that makes it a lightweight point-of-care option for low-volume testing facilities.
TestDirectly is now an LIS option for low-volume testing facilities
LigoLab, developers of enterprise software for medical laboratories and first care facilities, today announced that its direct-to-consumer platform, TestDirectly, is now equipped with Laboratory Information System (LIS) functionality that makes it a lightweight point-of-care option for low-volume testing facilities.
“TestDirectly supports instrument interfaces and manual resulting of tests, report generation and delivery, and reporting to health agencies,” said LigoLab CEO Suren Avunjian. “TestDirectly is an adaptable patient engagement tool with the flexibility to expand and grow with these smaller organizations as they scale their diagnostic services.”
For larger facilities processing thousands of samples a day, TestDirectly integrates with all LIS and Revenue Cycle Management (RCM) systems to boost testing capacity and improve turnaround times. It does this by replacing paper forms and manual order entry with an electronic workflow that covers the complete life-cycle of a case and a specimen, including patient and family self-registration and scheduling, capacity management, specimen collection, billing, specimen tracking and processing, automated report delivery, and reporting to public health departments and agencies in every state.
In addition to the new LIS functionality that caters to smaller facilities, other recent enhancements to the platform include the ability to link multiple family members to one account, and the on-demand download of travel documents for air travel.
“TestDirectly has evolved to meet the needs of our customers,” said Avunjian, who noted that hundreds of thousands of patients are processed every single day on the platform, one that supports every potential workflow for direct-to-consumer and direct-to-organizational testing.
To date, the TestDirectly network, made up of laboratories, specimen collection centers, urgent care facilities, and outpatient clinics located throughout the U.S., has collected, processed, and reported nearly seven million COVID-19 tests. Organizations ranging from long-term care facilities and employers to state and county health departments rely on TestDirectly for safe, fast, and easy testing.
For more information, please visit Solutions.TestDirectly.com.